Review about EVER Webinar 'Neurorecovery - When evidence from the bench meets results at the bedside'

For many years hundreds of pharmacological compounds with neuroprotective and neurorecovery-enhancing properties showed promising results in the preclinical stage but failed to translate these results into successful clinical evidence.

However, one compound succeeded and is nowadays labeled as evidence-based medicinal product proven by successful clinical trials and many different guideline inclusions – Cerebrolysin^®.

Two renowned clinicians, Professor Helmut Trimmel from Wiener Neustadt, Austria, and Professor Andrei Alexandrov from Memphis delivered very powerful and convincing messages in EVER Pharma’s fifth webinar in 2022 titled “When evidence from the bench meets results at the bedside”.

The full recording of the event can you find here. The summary report you can find below.